Using screening tools to identify neuropathic pain
نویسندگان
چکیده
منابع مشابه
Using screening tools to identify neuropathic pain.
a Senior Clinical Lecturer in Palliative Medicine, Clinical Teaching and Research Unit, St. Gemma’s Hospice, 329 Harrogate Road, Leeds LS17 6QD, UK b Centre d’Evaluation et de Traitement de la Douleur, CHU Ambroise Pare, Paris, France c Department of Neurology, University of Wisconsin Medical School, Wisconsin, USA d Department of Neurological Pain Research and Therapy, Universitätsklinikum Sch...
متن کاملTools for Assessing Neuropathic Pain
According to the latest definition, the term neuropathic pain refers to pain arising as a direct consequence of a lesion or disease affecting the somatosensory system [1]. When physicians and researchers use the term assessment of neuropathic pain, they may be referring to two distinct types of assessment: (1) assessing pain intensity and quality and possibly their treatmentinduced changes, and...
متن کاملScreening tools for neuropathic pain: are they adaptable in different languages and cultures?
Despite being related to a large variety of nerve lesions, neuropathic pain syndromes share common clinical symptoms and signs that are the result of particular mechanisms and necessitate specific management [1]. It therefore makes sense to examine the value of verbal descriptors and pain qualities as a basis for distinguishing neuropathic pain from other types of chronic pain. Pionneer work by...
متن کاملFrailty Screening Tools: Frail Detection to Primary Assessment
Frailty is a vulnerable situation among older adults which can lead to unfavorable health outcomes such as falls, mortality, functional decline and institutionalization. The increasing number of elderly people and low rate of mortality has necessitated the need for high-quality medical services for this aging population, and this has led to a high cost of geriatric health care. There exist a hu...
متن کاملPharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
Phosphodiesterase 4 (PDE4) has been established as a promising target in asthma andchronic obstructive pulmonary disease. PDE4B subtype selective inhibitors are known toreduce the dose limiting adverse effect associated with non-selective PDE4B inhibitors. Thismakes the development of PDE4B subtype selective inhibitors a desirable research goal. Toachieve this goal, ligand based pharmacophore m...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pain
سال: 2007
ISSN: 0304-3959
DOI: 10.1016/j.pain.2006.10.034